Stay updated on Bempegaldesleukin Combo in Advanced Tumors Clinical Trial
Sign up to get notified when there's something new on the Bempegaldesleukin Combo in Advanced Tumors Clinical Trial page.

Latest updates to the Bempegaldesleukin Combo in Advanced Tumors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check18 days agoChange DetectedA notice was added about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” during the transition period.SummaryDifference0.4%

- Check25 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2, indicating a website release update.SummaryDifference0.1%

- Check32 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision indicator in the study record history changed from v3.6.6 to v3.7.0, signaling an update to the page's version.SummaryDifference0.1%

- Check74 days agoChange DetectedThe study history has been updated to Revision: v3.6.6, indicating a new version entry in the page's historical log.SummaryDifference0.1%

Stay in the know with updates to Bempegaldesleukin Combo in Advanced Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bempegaldesleukin Combo in Advanced Tumors Clinical Trial page.